5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.53▼ | 1.54▼ | 1.54▼ | 1.72▼ | 2.41▼ |
MA10 | 1.53▼ | 1.55▼ | 1.56▼ | 2.19▼ | 2.53▼ |
MA20 | 1.55▼ | 1.57▼ | 1.62▼ | 2.46▼ | 2.07▼ |
MA50 | 1.59▼ | 1.78▼ | 2.08▼ | 2.60▼ | 4.91▼ |
MA100 | 1.78▼ | 2.19▼ | 2.32▼ | 2.21▼ | 50.47▼ |
MA200 | 2.15▼ | 2.51▼ | 2.31▼ | 3.58▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.014▲ | 0.021▲ | -0.149▼ | 0.570▲ |
RSI | 38.889▼ | 27.826▼ | 24.892▼ | 27.321▼ | 34.037▼ |
STOCH | 47.619 | 11.640▼ | 23.832 | 9.733▼ | 52.484 |
WILL %R | -85.714▼ | -96.000▼ | -92.308▼ | -96.429▼ | -66.322 |
CCI | -62.602 | -94.070 | -121.429▼ | -122.749▼ | -52.621 |
Monday, September 15, 2025 05:29 PM
Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease – ...
|
Monday, September 15, 2025 05:23 PM
SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company focused on rebalancing ...
|
Thursday, September 11, 2025 12:57 PM
Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease – ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 1.59 | 1.61 | 1.50 | 1.55 | 371,240 |
16/09/25 | 1.53 | 1.65 | 1.53 | 1.58 | 467,140 |
15/09/25 | 1.90 | 1.90 | 1.50 | 1.56 | 656,936 |
12/09/25 | 2.00 | 2.01 | 1.90 | 1.92 | 262,993 |
11/09/25 | 2.07 | 2.10 | 1.96 | 2.00 | 991,896 |
10/09/25 | 2.71 | 2.90 | 2.32 | 2.47 | 12,954,312 |
09/09/25 | 2.43 | 2.4678 | 2.20 | 2.33 | 1,170,978 |
08/09/25 | 2.88 | 2.8849 | 2.6806 | 2.82 | 84,938 |
05/09/25 | 2.87 | 2.88 | 2.75 | 2.87 | 87,564 |
04/09/25 | 2.7438 | 2.83 | 2.65 | 2.80 | 83,477 |
|
|
||||
|
|
||||
|
|